SARS-CoV-2 infection damages airway motile cilia and impairs mucociliary clearance - Génétique et Physiologie de l'Audition Accéder directement au contenu
Pré-Publication, Document De Travail Année : 2021

SARS-CoV-2 infection damages airway motile cilia and impairs mucociliary clearance

Rémy Robinot
Timothée Bruel
Céline Trébeau
Raphael Etournay
Marc Lecuit

Résumé

Understanding how SARS-CoV-2 spreads within the respiratory tract is important to define the parameters controlling the severity of COVID-19. We examined the functional and structural consequences of SARS-CoV-2 infection in a reconstituted human bronchial epithelium model. SARS-CoV-2 replication caused a transient decrease in epithelial barrier function and disruption of tight junctions, though viral particle crossing remained limited. Rather, SARS-CoV-2 replication led to a rapid loss of the ciliary layer, characterized at the ultrastructural level by axoneme loss and misorientation of remaining basal bodies. The motile cilia function was compromised, as measured in a mucociliary clearance assay. Epithelial defense mechanisms, including basal cell mobilization and interferon-lambda induction, ramped up only after the initiation of cilia damage. Analysis of SARS-CoV-2 infection in Syrian hamsters further demonstrated the loss of motile cilia in vivo . This study identifies cilia damage as a pathogenic mechanism that could facilitate SARS-CoV-2 spread to the deeper lung parenchyma.

Domaines

Immunologie
Fichier principal
Vignette du fichier
2020.10.06.328369v1.full.pdf (3.16 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

pasteur-03244406 , version 1 (01-06-2021)

Licence

Copyright (Tous droits réservés)

Identifiants

Citer

Rémy Robinot, Mathieu Hubert, Guilherme Dias de Melo, Françoise Lazarini, Timothée Bruel, et al.. SARS-CoV-2 infection damages airway motile cilia and impairs mucociliary clearance. 2021. ⟨pasteur-03244406⟩
164 Consultations
175 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More